Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Author
CADTH Canadian Drug Expert Committee
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Showing
141
-
160
of
214
Search:
'CADTH Canadian Drug Expert Committee'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
141
Clinical review report: Lanadelumab (Takhzyro) (Shire pharma Canada ULC) : indication : for routine prevention of attacks of hereditary angioedema in adolescents and adults
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
142
CADTH Canadian drug expert committee recommendation: Doravirine (Pifeltro -- Merck Canada Inc.) : indication: in combination with other antiretroviral medicinal products, for the t...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
143
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
144
CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
145
CADTH Canadian Drug Expert Committee recommendation: Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
146
CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
147
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
148
CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic--Ipsen Biopharmaceuticals Canada, Inc.) : indication : for the symptomatic treatment of...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
149
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
150
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
151
CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
152
CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
153
CADTH Canadian drug expert committee recommendation: Naltrexone hydrochloride and bupropion hydrochloride (Contrave -- Bausch Health, Canada Inc.) : indication: an adjunct to a red...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
154
CADTH Canadian Drug Expert Committee recommendation: Lumacaftor/Ivacaftor (Orkambi -- Vertex Pharmaceuticals (Canada) Incorporated) : indication : cystic fibrosis, F508del-cystic f...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
155
CADTH Canadian Drug Expert Committee Recommendation: Halobetasol propionate and tazarotene (Duobrii -- Bausch Health, Canada Inc.) : indication : psoriasis, moderate to severe plaq...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
156
CADTH Canadian Drug Expert Committee recommendation: Budesonide (Jorveza--Avir Pharma Inc.) : indication : eosinophilic esophagitis
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
157
CADTH Canadian Drug Expert Committee recommendation: Insulin degludec and liraglutide (Xultophy -- Novo Nordisk Canada Inc.) : indication : adjunct to lifestyle modifications, for...
Published 2019
CADTH
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
158
CADTH Canadian drug expert committee recommendation: Cyclosporine 0.1% (Verkazia -- Santen Canada Inc.) : indication : treatment of severe vernal keratoconjunctivitis in children f...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
159
CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
Read Now
160
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
CADTH
Canadian
Drug
Expert
Committee
...
”
1
2
3
4
5
6
7
8
9
10
11
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Author/Home?page=8&author=%22CADTH+Canadian+Drug+Expert+Committee%22&type=Author
Send by Email
×
Loading...